Proofstock
DashboardScreenerTrack RecordMethodology
DashboardScreenerTrack RecordMethodology
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

Proofstock
DashboardScreenerTrack RecordMethodology
As of
July 13, 2026
DashboardScreenerTrack RecordMethodology
← Dashboard

BBIO

Strong Bullish

BridgeBio Pharma, Inc.

Healthcare · Biotechnology · $12.95B market cap

Last close
$83.08
-3.27% · 1 day
as of Jul 13, 2026
60-day price history
Rating
Strong Bullish96thpercentile
Ranks #11 of 194 in Healthcare

Among the highest-conviction names in the universe on the composite score. Ranks in the 96th percentile overall.

Factor breakdown

Momentum
Quality
Value
Growth
Size
Low Volatility

What this stock is good at

  • Growth

What this stock is not strong at

Nothing notable on this side.

Rating history

Last 27 scored days
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

May 17, 2026 · 79thJul 13, 2026 · 96th

Recent factor inputs

The latest raw values feeding the six factors.

P/E
-22.1×
P/B
-6.4×
EV/EBITDA
-150.8×
FCF yield
—
ROE
7.2%
ROIC
-10.8%
Debt / equity
-1.49
Rev growth 3Y
355.2%
EPS growth 3Y
-6.2%
12-1 return
45.7%
3M return
11.4%
Realized vol
47.9%